Brian Rogers Appointed FX Solutions VP Global QARA, Clinical, and Compliance

FX has tapped Brian Rogers as the VP Global QARA, Clinical, and Compliance in a new role that will have oversight of the company’s Quality, Regulatory, Clinical, and Compliance functions.  Brian is based in the US headquarters in Dallas, Texas, but will also spend considerable time at the global headquarters in Viriat, France.

Brian Rogers is a professional engineer who has been working in medical devices for more than 20 years, including 10 years with Zimmer followed by 8 years in Switzerland with Stryker, Bracco, and Medacta, and he was most recently working with Argon Medical since returning to the US in April 2019.  Brian’s experiences have led him to this new global VP position with FX where he is eager to combine the FX-USA/FX-Global QARA Teams into one cohesive team with some major milestones in his sights.  Brian’s combined international professional experience, many certifications and trainings, and engineering background make him uniquely qualified for this role.

“Brian brings years of experience from both the US and Europe that will provide him the platform needed to join our existing teams in working toward some very important and major milestones for FX,” said FX CEO, Baptiste Martin.  “We see this as a critical role at a critical point in FX, and we couldn’t be more excited to have Brian join the FX Family,” he continued.

FX has a US Headquarters in Dallas, Texas and a Global Headquarters in Viriat, France.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”